AETHLON MEDICAL INC

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.

AEMDNasdaqHealthcareMedical Devices
$1.91 -0.22 (-10.33%)

Company Overview

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.

Price Chart

Historical Trend (Absolute Values)
AEMD Price
05/2005/2906/05

Financial Metrics

Market Capitalization$4.48M
P/E Ratio
Earnings Per Share (EPS)-$48
Dividend Yield
Beta (Volatility)1.321
Price to Book (P/B)0.2769
52-Week Range$1.36 - $29.60

LAST SCRARED: June 6, 2026

Compare AEMD

Analyze valuation multiples and growth parameters side-by-side with other public equities.

Compare Stock Now
VersusHub

© 2026 VersusHub. All rights reserved.